Chemoinformaics analysis of SCLARENE
Molecular Weight | 272.476 | nRot | 4 |
Heavy Atom Molecular Weight | 240.22 | nRig | 14 |
Exact Molecular Weight | 272.25 | nRing | 2 |
Solubility: LogS | -6.655 | nHRing | 0 |
Solubility: LogP | 6.276 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 54.7374 |
nHD | 0 | BPOL | 32.1026 |
QED | 0.415 |
Synth | 4.134 |
Natural Product Likeliness | 3.319 |
NR-PPAR-gamma | 0.4 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.964 |
Pgp-sub | 0 |
HIA | 0.002 |
CACO-2 | -4.731 |
MDCK | 0.00000733 |
BBB | 0.093 |
PPB | 0.93021 |
VDSS | 2.167 |
FU | 0.0304074 |
CYP1A2-inh | 0.188 |
CYP1A2-sub | 0.47 |
CYP2c19-inh | 0.307 |
CYP2c19-sub | 0.912 |
CYP2c9-inh | 0.378 |
CYP2c9-sub | 0.623 |
CYP2d6-inh | 0.01 |
CYP2d6-sub | 0.894 |
CYP3a4-inh | 0.228 |
CYP3a4-sub | 0.32 |
CL | 5.529 |
T12 | 0.04 |
hERG | 0.003 |
Ames | 0.015 |
ROA | 0.048 |
SkinSen | 0.633 |
Carcinogencity | 0.078 |
EI | 0.864 |
Respiratory | 0.941 |
NR-Aromatase | 0.093 |
Antiviral | No |
Prediction | 0.565404 |